1. Home
  2. DNA vs QDEL Comparison

DNA vs QDEL Comparison

Compare DNA & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

SELL

Current Price

$10.29

Market Cap

835.7M

Sector

Health Care

ML Signal

SELL

Logo QuidelOrtho Corporation

QDEL

QuidelOrtho Corporation

BUY

Current Price

$12.90

Market Cap

989.5M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
DNA
QDEL
Founded
2008
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
835.7M
989.5M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
DNA
QDEL
Price
$10.29
$12.90
Analyst Decision
Sell
Hold
Analyst Count
3
3
Target Price
$8.00
★ $14.67
AVG Volume (30 Days)
★ 3.4M
1.8M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 46.49
45.35
EPS
N/A
★ N/A
Revenue
$170,155,000.00
★ $2,730,200,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$13.05
$1.85
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.37
$9.92
52 Week High
$18.22
$35.58

Technical Indicators

Market Signals
Indicator
DNA
QDEL
Relative Strength Index (RSI) 47.78 52.22
Support Level $6.75 $11.63
Resistance Level $10.76 $12.85
Average True Range (ATR) 1.74 0.86
MACD -0.28 0.33
Stochastic Oscillator 0.43 61.02

Price Performance

Historical Comparison
DNA
QDEL

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About QDEL QuidelOrtho Corporation

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.

Share on Social Networks: